Partnerships:

To appease clients who demand the best pharmaceutical technology in the industry and to ensure that we fulfill some of the most stringent development timeframes, we continue to develop in-house capabilities in controlled release products ranging from development and pre-formulation design right through to regulatory approval.

IntelliPharmaCeutics has provided current and past clients with multiple services such as life cycle management and the enhancement of new chemical entities (NCEs). We continue to develop a wide array of highly successful products for exclusive licensing projects and are also seeking to bring late stage products to market.

In any partnership agreement IntelliPharmaCeutics brings speed, technology and tenacity; we will use our intelligent drug delivery systems to aggressively position ourselves at the forefront of any controlled release market.

IntelliPharmaCeutics collaborative development and licensing agreements are based on the following:

	Our proven track record
	An unsurpassed technology platform
	The expertise of industry leaders
	Our scientific breakthroughs

Once we have partnered, the promise is simple: breakthrough technology with rewards and results in a highly competitive timeframe. 

For more information contact Yogish Kamath, Director of New Business Development at ykamath@intellipharmaceutics.com